Related Experiment Video
Updated: Jul 12, 2026
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Long-term study on symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients
Maurizia Debiaggi1, Filippo Canducci, Cristina Terulla
1Dipartimento Scienze Morfologiche Eidologiche e Cliniche, Sezione Microbiologia, Università di Pavia, Italy. mdeb@unipv.it
Abstract:
From October 2004 through October 2006 a study was performed to evaluate the prevalence of human Metapneumovirus (hMPV) infection in adult hematopoietic stem cell transplant (HSCT) recipients. Sequential nasopharyngeal aspirates (NPA) were collected independently from respiratory symptoms and evaluated for hMPV-RNA by polymerase chain reaction (PCR) and sequence analysis. Results indicate epidemiological and molecular differences between the 2004-2005 and 2005-2006 periods and that hMPV seems not to symptomatically affect HSCT patients or cause late respiratory sequelae. In addition, data collected suggest a hospital origin of hMPV infection in most HSCT patients during the 2004-2005 period.
Insights
Human Metapneumovirus (hMPV) infection was studied in adult hematopoietic stem cell transplant (HSCT) recipients. Most HSCT patients did not show symptoms or long-term respiratory issues from hMPV, suggesting a hospital origin.
Area of Science:
- Virology
- Immunology
- Transplant Medicine
Background:
- Hematopoietic stem cell transplant (HSCT) recipients are vulnerable to respiratory infections.
- Human Metapneumovirus (hMPV) is a significant respiratory pathogen.
- Understanding hMPV prevalence in immunocompromised populations is crucial.
Purpose of the Study:
- To evaluate the prevalence of human Metapneumovirus (hMPV) infection in adult HSCT recipients.
- To investigate potential symptomatic effects and respiratory sequelae of hMPV in this population.
- To explore the origin of hMPV infections in HSCT patients.
Main Methods:
- Prospective study from October 2004 to October 2006.
- Collection of sequential nasopharyngeal aspirates (NPA) from adult HSCT recipients.
- Detection of hMPV-RNA using polymerase chain reaction (PCR) and sequence analysis.
Main Results:
- Epidemiological and molecular differences observed between the 2004-2005 and 2005-2006 seasons.
- hMPV infection did not appear to cause symptomatic illness or late respiratory sequelae in HSCT patients.
- Most hMPV infections in 2004-2005 were suggested to originate from within the hospital.
Conclusions:
- hMPV infection is prevalent but generally asymptomatic in adult HSCT recipients.
- HSCT patients do not typically experience severe respiratory complications from hMPV.
- Hospital-acquired infections are a likely source of hMPV in HSCT patients, particularly during certain seasons.
